Kyle Cooper

Dr. Cooper was born and raised in Michigan. He attended medical school at the University of Toledo, completed the Clinical IR Pathway (precursor to the IR/DR Residency) at “The” Ohio State University, and concluded his training with a VIR Fellowship at Miami Cardiac & Vascular Institute. He spent two years as faculty at the University of Michigan before joining Loma Linda University in 2018, where he currently serves as the Associate Director of IR and Program Director of the Integrated and Independent IR training programs. His clinical and research priorities focus on vascular disease (venous thromboembolism, complex veno-occlusive disease, peripheral arterial disease, aneurysms, dissections, and dialysis interventions), as well as portomesenteric and lymphatic interventions and percutaneous cholangioscopy.

Dr. Cooper was born and raised in Michigan. He attended medical school at the University of Toledo, completed the Clinical IR Pathway (precursor to the IR/DR Residency) at “The” Ohio State University, and concluded his training with a VIR Fellowship at Miami Cardiac & Vascular Institute. He spent two years as faculty at the University of Michigan before joining Loma Linda University in 2018, where he currently serves as the Associate Director of IR and Program Director of the Integrated and Independent IR training programs. His clinical and research priorities focus on vascular disease (venous thromboembolism, complex veno-occlusive disease, peripheral arterial disease, aneurysms, dissections, and dialysis interventions), as well as portomesenteric and lymphatic interventions and percutaneous cholangioscopy.

A member of the Miami Cardiac & Vascular Institute and Miami Cancer Institute physician team, Dr. Gandhi specializes in minimally invasive treatments for peripheral vascular disease, cancer, and other diseases.

Dr. Gandhi did his undergraduate studies at Northwestern University and Harvard University. He graduated summa cum laude. He received his degree in medicine from Northwestern University Medical School, where he also graduated with honors. Following medical school, he completed a surgical internship at Cornell University Medical Center and New York Presbyterian Hospital. He completed his residency training and fellowship at UCLA Medical Center.

Dr. Gandhi also dedicated an entire year to biomedical research at Memorial Sloan-Kettering Cancer Center and also served as a research fellow at the National Institutes of Health (NIH). Prior to joining Miami Cardiac & Vascular Institute, he was an international visiting scholar at Asan Medical Center/University of Ulsan Medical School in Seoul, South Korea. He has published numerous scientific papers, authored several textbook chapters and presented his research at national and international meetings.

He is also a fellow of the Society for Vascular Medicine and a fellow of the Society of Interventional Radiology. He is the co-author of the textbook Interventional Oncology. Dr. Gandhi is also a program director for the International Symposium on Endovascular Therapy (ISET) and Symposium on Clinical Interventional Oncology (CIO).

Dr. Cooper was born and raised in Michigan. He attended medical school at the University of Toledo, completed the Clinical IR Pathway (precursor to the IR/DR Residency) at “The” Ohio State University, and concluded his training with a VIR Fellowship at Miami Cardiac & Vascular Institute. He spent two years as faculty at the University of Michigan before joining Loma Linda University in 2018, where he currently serves as the Associate Director of IR and Program Director of the Integrated and Independent IR training programs. His clinical and research priorities focus on vascular disease (venous thromboembolism, complex veno-occlusive disease, peripheral arterial disease, aneurysms, dissections, and dialysis interventions), as well as portomesenteric and lymphatic interventions and percutaneous cholangioscopy.